根据深圳商报.读创客户端记者此前报道，近日，雀巢在全球多个国家和地区召回部分批次婴幼儿配方奶粉产品，引发市场关注。雀巢在官网发文表示， 公司对用于生产可能受影响的婴幼儿配方奶粉产品的所有花生四烯酸油(ARA)及相关油脂混合物进行了检测。雀巢解释说，发现供应商提供的这种油脂原 料存在质量问题，相关批次婴幼儿配方奶粉中可能存在蜡样芽孢杆菌，这种细菌可能引起食源性疾病。但雀巢在公告中未公开供应商的具体名称。 此前报道： 根据上交所官网1月12日发布的公告，嘉必优收到了上交所监管工作函。该函件督促嘉必优及时回复上交所监管函件，并依法履行信息披露义务。 | 证券代码 - - - 证券简称 - - - 监管类型 - - 处理事由 | 涉及对象 | 处理日期 | | --- | --- | --- | | 688089 嘉必优 | 监管工作函 关于督促公司及时回复本所监管函件并依法履行信息披露义务的工 上市公司 | 2026-01-12 | 从目前的公开信息中，尚不知上交所督促嘉必优回复该所监管函件的具体内容为何。但公开资料显示，日前，雀巢多国召回部分婴幼儿配方奶粉，嘉必优 疑被卷入。有市场分析认为，不排除上交所所发函件与 ...

Core Insights - The Ministry of Industry and Information Technology of China has officially released the first batch of the "Biomanufacturing Pilot Capability Construction Platform List," with Jia Bi You Biotechnology (Wuhan) Co., Ltd. being recognized for its strong technological foundation and industrial application capabilities in biomanufacturing [1][2] - Biomanufacturing has been elevated to a national strategic level, identified as a key growth point in the "14th Five-Year Plan," and is expected to play a crucial role in supporting China's dual carbon goals and green transformation [2][6] - Jia Bi You is positioned as a "full-chain player" in the biomanufacturing sector, having successfully industrialized key nutritional ingredients and expanded its product line to include high-value items such as DHA and HMOs [3][6] Industry Context - The emphasis on biomanufacturing in the "14th Five-Year Plan" reflects the need for China to enhance its economic structure and address global industrial competition, particularly in high-value areas like green manufacturing and functional molecules [2][4] - The selection of "symbolic projects" by regulatory authorities aims to identify companies that can represent China's competitiveness in high-end nutritional raw materials and green manufacturing [2][4] Company Developments - Jia Bi You has been recognized for its innovative capabilities, having its product 2'-fucosyllactose (2'-FL) selected as a "symbolic product" in biomanufacturing, alongside its inclusion in the high-performance bioreactor innovation list [3][6] - The company is actively implementing an "AI + synthetic biology" strategy, enhancing its research and manufacturing processes through automation and advanced technologies [4][5] - Jia Bi You has established an intelligent research platform and is developing proprietary computational tools to optimize its biomanufacturing processes, significantly improving efficiency and product quality [5][6] Strategic Positioning - Jia Bi You is strategically aligned with national policies, having developed a platform-based approach that integrates AI and synthetic biology to enhance its production capabilities [7][8] - The company has proactively engaged in regional industrial planning, positioning itself to benefit from favorable policies and market opportunities in the biomanufacturing sector [7][8]